Terms: = Colorectal cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Treatment
513 results:
1. Dual inhibition of SUMOylation and MEK conquers myc-expressing KRAS-mutant cancers by accumulating DNA damage.
Kotani H; Oshima H; Boucher JC; Yamano T; Sakaguchi H; Sato S; Fukuda K; Nishiyama A; Yamashita K; Ohtsubo K; Takeuchi S; Nishiuchi T; Oshima M; Davila ML; Yano S
J Biomed Sci; 2024 Jul; 31(1):68. PubMed ID: 38992694
[TBL] [Abstract] [Full Text] [Related]
2. Manuka honey's anti-metastatic impact on colon cancer stem-like cells: unveiling its effects on epithelial-mesenchymal transition, angiogenesis and telomere length.
Cianciosi D; Forbes-Hernandez T; Armas Diaz Y; Elexpuru-Zabaleta M; Quiles JL; Battino M; Giampieri F
Food Funct; 2024 Jul; 15(13):7200-7213. PubMed ID: 38896046
[TBL] [Abstract] [Full Text] [Related]
3. MYG1 drives glycolysis and colorectal cancer development through nuclear-mitochondrial collaboration.
Chen J; Duan S; Wang Y; Ling Y; Hou X; Zhang S; Liu X; Long X; Lan J; Zhou M; Xu H; Zheng H; Zhou J
Nat Commun; 2024 Jun; 15(1):4969. PubMed ID: 38862489
[TBL] [Abstract] [Full Text] [Related]
4. Structure-Guided Discovery and Preclinical Assessment of Novel (Thiophen-3-yl)aminopyrimidine Derivatives as Potent ERK1/2 Inhibitors.
Shuai W; Xiao H; Yang P; Zhang Y; Bu F; Wu Y; Sun Q; Wang G; Ouyang L
J Med Chem; 2024 Apr; 67(8):6425-6455. PubMed ID: 38613499
[TBL] [Abstract] [Full Text] [Related]
5. Identification of unique rectal cancer-specific subtypes.
Kisakol B; Matveeva A; Salvucci M; Kel A; McDonough E; Ginty F; Longley DB; Prehn JHM
Br J Cancer; 2024 May; 130(11):1809-1818. PubMed ID: 38532103
[TBL] [Abstract] [Full Text] [Related]
6. Prediction of potential mechanisms of rhubarb therapy for colorectal cancer based on network pharmacological analysis and molecular docking.
Yang F; Li X; Zhang Y; Ren Y; Zhang J; Xiao K
Medicine (Baltimore); 2024 Mar; 103(12):e37477. PubMed ID: 38518016
[TBL] [Abstract] [Full Text] [Related]
7. miR-575/RIPK4 axis modulates cell cycle progression and proliferation by inactivating the Wnt/β-catenin signaling pathway through inhibiting RUNX1 in colon cancer.
Wang Q; Lu W; Lu L; Wu R; Wu D
Mol Cell Biochem; 2024 Jul; 479(7):1747-1766. PubMed ID: 38480605
[TBL] [Abstract] [Full Text] [Related]
8. Network Pharmacology Analysis on the Mechanism of Xihuangwan in Treating Rectal cancer and Radiation Enteritis.
Lv M; Ding R; Ma P; Feng Y; Zeng S; Zhang Y; Shen W; Guan W; Xiangyu E; Zeng H; Yu J
Curr Pharm Des; 2024; 30(9):683-701. PubMed ID: 38415445
[TBL] [Abstract] [Full Text] [Related]
9. Kurarinone targets JAK2-STAT3 signaling in colon cancer-stem-like cells.
Prajapati KS; Kumar S
Cell Biochem Funct; 2024 Mar; 42(2):e3959. PubMed ID: 38390770
[TBL] [Abstract] [Full Text] [Related]
10. Multiomic molecular characterization of the response to combination immunotherapy in MSS/pMMR metastatic colorectal cancer.
Takei S; Tanaka Y; Lin YT; Koyama S; Fukuoka S; Hara H; Nakamura Y; Kuboki Y; Kotani D; Kojima T; Bando H; Mishima S; Ueno T; Kojima S; Wakabayashi M; Sakamoto N; Kojima M; Kuwata T; Yoshino T; Nishikawa H; Mano H; Endo I; Shitara K; Kawazoe A
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38336371
[TBL] [Abstract] [Full Text] [Related]
11. FSTL3 promotes tumor immune evasion and attenuates response to anti-PD1 therapy by stabilizing c-myc in colorectal cancer.
Li H; Zheng N; Guo A; Tang W; Li M; Cao Y; Ma X; Cao H; Ma Y; Wang H; Zhao S
Cell Death Dis; 2024 Feb; 15(2):107. PubMed ID: 38302412
[TBL] [Abstract] [Full Text] [Related]
12. Linderapyrone analogue LPD-01 as a cancer treatment agent by targeting importin7.
Kitagawa T; Matsumoto T; Ohta T; Yoshida T; Saito Y; Nakayama Y; Hadate Y; Ashihara E; Watanabe T
J Nat Med; 2024 Mar; 78(2):370-381. PubMed ID: 38265612
[TBL] [Abstract] [Full Text] [Related]
13. Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression.
Chen Y; Ying Y; Ma W; Ma H; Shi L; Gao X; Jia M; Li M; Song X; Kong W; Chen W; Zheng X; Muluh TA; Wang X; Wang M; Shu XS
Cancer Res; 2024 Apr; 84(8):1237-1251. PubMed ID: 38241700
[TBL] [Abstract] [Full Text] [Related]
14. The radiation- and chemo-sensitizing capacity of diclofenac can be predicted by a decreased lactate metabolism and stress response.
Schwab M; Dezfouli AB; Khosravi M; Alkotub B; Bauer L; Birgani MJT; Multhoff G
Radiat Oncol; 2024 Jan; 19(1):7. PubMed ID: 38229111
[TBL] [Abstract] [Full Text] [Related]
15. Efficacy, safety and genomic analysis of SCT200, an anti-EGFR monoclonal antibody, in patients with fluorouracil, irinotecan and oxaliplatin refractory RAS and BRAF wild-type metastatic colorectal cancer: a phase Ⅱ study.
Yang L; Zhang W; Fan N; Cao P; Cheng Y; Zhu L; Luo S; Zong H; Bai Y; Zhou J; Deng Y; Ba Y; Liu T; Aili M; Yin X; Gu K; Dai G; Ying J; Shi J; Gao Y; Li W; Yu G; Xie L; Gai W; Wang Y; Meng P; Shi Y
EBioMedicine; 2024 Feb; 100():104966. PubMed ID: 38217945
[TBL] [Abstract] [Full Text] [Related]
16. Integrated whole transcriptome profiling revealed a convoluted circular RNA-based competing endogenous RNAs regulatory network in colorectal cancer.
Mollanoori H; Ghelmani Y; Hassani B; Dehghani M
Sci Rep; 2024 Jan; 14(1):91. PubMed ID: 38167453
[TBL] [Abstract] [Full Text] [Related]
17. The feedback loop of EFTUD2/c-myc impedes chemotherapeutic efficacy by enhancing EFTUD2 transcription and stabilizing c-myc protein in colorectal cancer.
Zhu X; Li C; Gao Y; Zhang Q; Wang T; Zhou H; Bu F; Chen J; Mao X; He Y; Wu K; Li N; Luo H
J Exp Clin Cancer Res; 2024 Jan; 43(1):7. PubMed ID: 38163859
[TBL] [Abstract] [Full Text] [Related]
18. RTKN2 knockdown alleviates the malignancy of breast cancer cells by regulating the Wnt/β-catenin pathway.
Zhang X; Wang J; Li H
Sci Rep; 2023 Dec; 13(1):23023. PubMed ID: 38155217
[TBL] [Abstract] [Full Text] [Related]
19. Acetylcorynoline Induces Apoptosis and G2/M Phase Arrest through the c-myc Signaling Pathway in Colon cancer Cells.
Park YR; Jee W; Park SM; Kim SW; Jung JH; Kim H; Kim KI; Jang HJ
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139419
[TBL] [Abstract] [Full Text] [Related]
20. Resistomycin Inhibits Wnt/β-Catenin Signaling to Induce the Apoptotic Death of Human colorectal cancer Cells.
Zhu Y; Zhang E; Gao H; Shang C; Yin M; Ma M; Liu Y; Zhang X; Li X
Mar Drugs; 2023 Nov; 21(12):. PubMed ID: 38132944
[TBL] [Abstract] [Full Text] [Related]
[Next]
